Literature DB >> 11253364

Apoptosis in neurodegenerative disorders.

M P Mattson1.   

Abstract

Neuronal death underlies the symptoms of many human neurological disorders, including Alzheimer's, Parkinson's and Huntington's diseases, stroke, and amyotrophic lateral sclerosis. The identification of specific genetic and environmental factors responsible for these diseases has bolstered evidence for a shared pathway of neuronal death--apoptosis--involving oxidative stress, perturbed calcium homeostasis, mitochondrial dysfunction and activation of cysteine proteases called caspases. These death cascades are counteracted by survival signals, which suppress oxyradicals and stabilize calcium homeostasis and mitochondrial function. With the identification of mechanisms that either promote or prevent neuronal apoptosis come new approaches for preventing and treating neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11253364     DOI: 10.1038/35040009

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  403 in total

1.  Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death.

Authors:  Chengbiao Lu; Weiming Fu; Guy S Salvesen; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

2.  Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines.

Authors:  Venugopalan D Nair; C Warren Olanow; Stuart C Sealfon
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

Review 3.  Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility?

Authors:  Charles P Gilman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 4.  Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

5.  Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain.

Authors:  Kyung-Ah Park; Nuri Yun; Dong-Ik Shin; So Yoen Choi; Hyun Kim; Won-Ki Kim; Yuzuru Kanakura; Hirohiko Shibayama; Young J Oh
Journal:  J Neural Transm (Vienna)       Date:  2010-10-06       Impact factor: 3.575

Review 6.  Cellular strategies of estrogen-mediated neuroprotection during brain development.

Authors:  Malgorzata Kajta; Cordian Beyer
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 7.  Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

Review 8.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

9.  The neuroprotective role of ferrostatin-1 under rotenone-induced oxidative stress in dopaminergic neuroblastoma cells.

Authors:  Parijat Kabiraj; Carlos A Valenzuela; Jose E Marin; David A Ramirez; Lois Mendez; Michael S Hwang; Armando Varela-Ramirez; Karine Fenelon; Mahesh Narayan; Rachid Skouta
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371

Review 10.  Cell death in the nervous system: lessons from insulin and insulin-like growth factors.

Authors:  Isabel Varela-Nieto; Enrique J de la Rosa; Ana I Valenciano; Yolanda León
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.